EQ

Equillium Inc.

Price

$2.45

return (12m)

34.62%

p/e

-13.69

p/bv

4.40

DIVIDEND YIELD

0.00%

EQ price

Equillium

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EQ

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.52%

3 months

-15.52%

1 year

34.62%

2 years

140.20%

5 years

-60.74%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals EQ

Valuation

P/E

-13.69

Sector -4.26

Industry -4.26

P/BV

4.40

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

4.20

Sector 1.25

Industry 1.25

P/Net Current Assets

4.45

Sector -5.47

Industry -5.47

P/Working Capital

4.44

Sector -1.10

Industry -1.10

EPS

-0.16

Sector -1.94

Industry -1.94

BVPS

0.50

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-32.13%

Sector -61.50%

Industry -61.50%

ROA

-30.68%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

23.38

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.95

Sector 0.43

Industry 0.43

Liabilities/Assets

0.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-14.35%

Sector -

Industry -

Fundamentals EQ

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EQ Equillium Inc.	$2.45	25.64%	0.00%	-13.69	4.40	-32.13%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EQ Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Equillium

Equillium Inc.

Average Investor10 user rating

4.0 (0 people)

United States

9 years

Founded: 2017

2018

Time since IPO - 8 years

31

Employees

Equillium Inc. (United States) is listed on the Nasdaq and has a market capitalization of $246.40 million, with shareholders equity totaling $56.02 million.

The company employs approximately 31 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Equillium Inc. reported $- in revenue, generating net income of $-18.00 million.

Key financial metrics include a P/E ratio of -13.69, a price-to-book (P/B) ratio of 4.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EQ.

Market cap

$246.40 million

Net worth

$56.02 million

$56,020,000.00

Assets

$58.67 million

$58,670,000.00

Total Shares Outstanding

112.00 million

112,000,000

Average Daily Trading Volume

$689.04 Thousand

$689,035.64

Sector

Health Care

Industry

Biotechnology

EQ revenue and profits

Financial Results EQ

DRAG THE FRAME TO SEE MORE DATA

EQ cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Equillium (EQ) today?

A cotação de Equillium (EQ) hoje está em US$ 2.45, com uma variação de 34.62% em relação ao último ano. A cotação de Equillium (EQ) iniciou o ano negociando na casa dos US$ 1.55 e hoje está em US$ 2.45. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Equillium (EQ) e dados de ações do Ibovespa e mercados internacionais.

Quando Equillium (EQ) paga dividendos?

Equillium (EQ) não distribuiu dividendos no último ano.

Is Equillium (EQ) a good investment?

Atualmente, Equillium (EQ) está cotada a US$ 2.45, com um P/L de -13.69, representando um desvio de -514% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 34.62 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 34.62%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Equillium (EQ) stock?

Investir em ações de Equillium (EQ) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Equillium (EQ) yield today?

A rentabilidade de Equillium (EQ) foi de 6.52% no último mês, 34.62% no último ano e -60.74% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Equillium (EQ) hoje, o investimento total seria de US$ 245.00, com base na cotação atual de US$ 2.45.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 329.82
Em 5 anos: US$ 96.19
Em 10 anos: US$ 245.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

EQ

Equillium Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment EQ

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING EQ WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Equillium

Equillium Inc.

United States

9 years

2018

31

PROFIT X PRICE EQ

Financial Results EQ

EQ cash flow

Asset, Revenue and Profit Growth - EQ

EQ balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions